Method for treating non-Hodgkin's lymphoma

Details for Australian Patent Application No. 2007267803 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Foley, Kevin

Agent Davies Collison Cave

Pub. Number AU-B-2007267803

PCT Pub. Number WO2007/140002

Priority 60/808,341 25.05.06 US

Filing date 25 May 2007

Wipo publication date 6 December 2007

Acceptance publication date 25 August 2011

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/538 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/140002 Priority application(s): WO2007/140002

25 August 2011 Application Accepted

  Published as AU-B-2007267803

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267805-Primers for use in detecting metallobeta-lactamases

2007267801-Administration of the REG1 anticoagulation system